Drug Type Small molecule drug |
Synonyms Acetazolamide/Atomoxetine |
Target |
Mechanism CAs inhibitors(Carbonic anhydrases inhibitors), NET inhibitors(Norepinephrine transporter inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H22ClNO |
InChIKeyLUCXVPAZUDVVBT-UNTBIKODSA-N |
CAS Registry82248-59-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity Hypoventilation Syndrome | Phase 2 | IT | 21 Jun 2022 | |
Obesity Hypoventilation Syndrome | Phase 2 | IT | Apnimed, Inc.Startup | 21 Jun 2022 |